OKYO earnings date and last-quarter result: next report 2026-08-10, last quarter miss, P/E -13.91. Updated 2026-07-23.
OKYO Pharma (OKYO) Research Hub
OKYO Pharma (OKYO) trades on NASDAQ, GB in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.44 USD (+2.86%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -13.91, market cap 0.06B. This hub links to the full technical, earnings and options research available for OKYO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 1.44 USD (+2.86%) |
| 52-week range | 1.26 USD – 1.75 USD |
| Trend regime | Range |
| 14-day RSI | 48.2 (Neutral) |
| Trailing P/E | -13.91 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for OKYO
Covered Call on OKYO: how it works, illustrative setup around the real 1.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OKYO: how it works, illustrative setup around the real 1.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OKYO: how it works, illustrative setup around the real 1.44 USD price, max profit/loss, breakeven and when to use it. Educational.
OKYO technical analysis: range, last 1.44 USD, RSI 48.2, 52w range 1.26 USD–1.75 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is OKYO in?
OKYO Pharma (OKYO) is classified under Healthcare (Biotechnology), listed on NASDAQ, GB.
Is OKYO in an uptrend or downtrend?
As of 2026-10-26, OKYO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OKYO's trailing P/E ratio?
OKYO's trailing P/E is -13.91, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does OKYO next report earnings?
OKYO is next scheduled to report earnings on 2026-08-10.